Literature DB >> 25850341

Association of overexpression of efflux pump genes with antibiotic resistance in Pseudomonas aeruginosa strains clinically isolated from urinary tract infection patients.

Katsumi Shigemura1,2, Kayo Osawa2,3, Ayaka Kato3, Issei Tokimatsu2, Soichi Arakawa1,2, Toshiro Shirakawa1,3,4, Masato Fujisawa1.   

Abstract

There are several mechanisms for antibiotic-resistant Pseudomonas aeruginosa. The purpose of this study is to investigate the association between the expression of efflux pump-coding genes and antibiotic resistance in P. aeruginosa causing urinary tract infections (UTIs). We extracted the RNA from 105 clinical strains of P. aeruginosa isolated from UTI patients with full data on antibiotic MICs and assayed real-time quantitative reverse-transcription PCR. We investigated the gene expressions of four resistance nodulation cell division-type multi-drug efflux pump systems (MexAB-OprM, MexCD-OprJ, MexEF-OprN and MexXY(-OprA)) and the correlation of the MICs of nine antibiotics, risk factors and antibiotic resistance-related genes with expressions of mexB, mexC, mexE and mexY. Multivariate statistical data demonstrated a significant relationship between increased expression of mexB or mexC and complicated UTI (Odds ratio=8.03, P<0.001 and Odds ratio=8.86, P=0.032, respectively). We also found a significant association between the increased expression of mexC and resistance to levofloxacin (LVFX) (Odds ratio=4.48, P=0.035). In conclusion, increased expression of mexC leads to LVFX resistance in P. aeruginosa causing UTI. These results contribute to our knowledge of the efflux pump system and antibiotic resistance.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25850341     DOI: 10.1038/ja.2015.34

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  31 in total

1.  Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coli.

Authors:  Jennifer H Han; Irving Nachamkin; Pam Tolomeo; Xiangqun Mao; Warren B Bilker; Ebbing Lautenbach
Journal:  J Infect Dis       Date:  2012-09-10       Impact factor: 5.226

Review 2.  Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region.

Authors:  Po-Ren Hsueh; Daryl J Hoban; Yehuda Carmeli; Shey-Ying Chen; Sunita Desikan; Marissa Alejandria; Wen-Chien Ko; Tran Quang Binh
Journal:  J Infect       Date:  2011-06-12       Impact factor: 6.072

3.  Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa.

Authors:  N Masuda; E Sakagawa; S Ohya; N Gotoh; H Tsujimoto; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

4.  Efflux pump genes and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from lower respiratory tract infections acquired in an intensive care unit.

Authors:  Burcin Ozer; Nizami Duran; Yusuf Onlen; Lutfu Savas
Journal:  J Antibiot (Tokyo)       Date:  2011-11-16       Impact factor: 2.649

5.  Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates.

Authors:  Maria Rosalia Pasca; Claudia Dalla Valle; Ana Luisa De Jesus Lopes Ribeiro; Silvia Buroni; Maria Cristiana Papaleo; Silvia Bazzini; Claudia Udine; Maria Loreto Incandela; Silvio Daffara; Renato Fani; Giovanna Riccardi; Piero Marone
Journal:  Microb Drug Resist       Date:  2011-07-28       Impact factor: 3.431

6.  Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.

Authors:  Katsumi Shigemura; Kazushi Tanaka; Fukashi Yamamichi; Toshiro Shirakawa; Hideaki Miyake; Masato Fujisawa
Journal:  Int J Antimicrob Agents       Date:  2012-10-13       Impact factor: 5.283

7.  Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 114 clinical isolates of Pseudomonas aeruginosa derived from urinary tract infections and their rapid detection by denaturing high-performance liquid chromatography.

Authors:  Minori Matsumoto; Katsumi Shigemura; Toshiro Shirakawa; Yuzo Nakano; Hideaki Miyake; Kazushi Tanaka; Shohiro Kinoshita; Soichi Arakawa; Masato Kawabata; Masato Fujisawa
Journal:  Int J Antimicrob Agents       Date:  2012-08-10       Impact factor: 5.283

8.  Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosa.

Authors:  Neda Gorgani; Scott Ahlbrand; Andrew Patterson; Nader Pourmand
Journal:  Int J Antimicrob Agents       Date:  2009-08-04       Impact factor: 5.283

Review 9.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

10.  Pseudomonas aeruginosa: resistance to the max.

Authors:  Keith Poole
Journal:  Front Microbiol       Date:  2011-04-05       Impact factor: 5.640

View more
  8 in total

1.  MIC score, a new tool to compare bacterial susceptibility to antibiotics application to the comparison of susceptibility to different penems of clinical strains of Pseudomonas aeruginosa.

Authors:  Cédric Bretonnière; Adeline Maitte; Jocelyne Caillon; Gilles Potel; David Boutoille; Cédric Jacqueline; Christophe Guitton
Journal:  J Antibiot (Tokyo)       Date:  2016-03-30       Impact factor: 2.649

Review 2.  Sequencing-based methods and resources to study antimicrobial resistance.

Authors:  Manish Boolchandani; Alaric W D'Souza; Gautam Dantas
Journal:  Nat Rev Genet       Date:  2019-06       Impact factor: 53.242

3.  Overexpression of Efflux Pump in Multiresistant Pseudomonas aeruginosa: How You Will Discover and Treat It?

Authors:  Sun Hoe Koo
Journal:  Infect Chemother       Date:  2015-06

4.  Comparative genomics of Pseudomonas fluorescens subclade III strains from human lungs.

Authors:  Brittan S Scales; John R Erb-Downward; Ian M Huffnagle; John J LiPuma; Gary B Huffnagle
Journal:  BMC Genomics       Date:  2015-12-07       Impact factor: 3.969

5.  Coexistence of Virulence Factors and Efflux Pump Genes in Clinical Isolates of Pseudomonas aeruginosa: Analysis of Biofilm-Forming Strains from Iran.

Authors:  Shahram Shahraki Zahedani; Hamed Tahmasebi; Mojdeh Jahantigh
Journal:  Int J Microbiol       Date:  2021-05-21

Review 6.  Environmental Spread of Antibiotic Resistance.

Authors:  Nicholas Skandalis; Marlène Maeusli; Dimitris Papafotis; Sarah Miller; Bosul Lee; Ioannis Theologidis; Brian Luna
Journal:  Antibiotics (Basel)       Date:  2021-05-27

7.  Molecular Epidemiology and Mechanisms of High-Level Resistance to Meropenem and Imipenem in Pseudomonas aeruginosa.

Authors:  Noha Anwar Hassuna; Marwa K Darwish; Mohamed Sayed; Reham Ali Ibrahem
Journal:  Infect Drug Resist       Date:  2020-01-30       Impact factor: 4.003

8.  Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa.

Authors:  Lei Zhao; Shiqi Wang; Xiaobing Li; Xiaojing He; Lingyan Jian
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-05       Impact factor: 4.887

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.